Search

Your search keyword '"Remicade (Medication) -- Adverse and side effects"' showing total 20 results
Start Over Descriptor "Remicade (Medication) -- Adverse and side effects"
20 results on '"Remicade (Medication) -- Adverse and side effects"'

1. Tuberculosis associated witih inflximab, a tumor necrosis factor alpha-neutralizing agent

Author

Keane, Joseph, Gershon, Sharon, Wise, Robert P., Mirabile-Levens, Elizabeth, Kasznica, John, Schwieterman, William D., Siegel, Jeffrey N., and Braun, M. Miles

Subjects
Remicade (Medication) -- Adverse and side effects, Tuberculosis -- Causes of, Rheumatoid arthritis -- Drug therapy, Crohn's disease -- Drug therapy
Abstract

The drug Remicade may cause tuberculosis in patients who take the drug for rheumatoid arthritis or Crohn's disease. Remicade blocks the activity of tumor necrosis factor-alpha, which is an immune system protein. This supports the idea that tumor necrosis factor-alpha may protect people from tuberculosis.

Published
2001

3. Adverse reactions to TNF-a inhibitors in rheumatoid arthritis

Author

Day, Richard

Subjects
Remicade (Medication) -- Adverse and side effects, Etanercept (Medication) -- Adverse and side effects, Enbrel (Medication) -- Adverse and side effects, Infliximab -- Adverse and side effects, Rheumatoid arthritis -- Drug therapy
Published
2002

4. An Arthritis Drug Raises the Risk of TB

Subjects
Centocor Inc. -- Product information, Remicade (Medication) -- Adverse and side effects, Tuberculosis -- Risk factors, Crohn's disease -- Complications, Rheumatoid arthritis -- Complications, Pharmaceutical industry -- Product information
Published
2001

5. Data Suggest Infliximab Is Safe in Pregnancy

Author

MULCAHY, NICHOLAS

Subjects
Infliximab (Medication) -- Adverse and side effects, Remicade (Medication) -- Adverse and side effects, Pregnancy, Miscarriage -- Risk factors, Birth defects -- Risk factors
Abstract

ATLANTA -- Information is emerging about the effect of infliximab in pregnancy, and the initial results indicate no higher risk of miscarriage or birth defects, Dr. Jeffry A. Katz said [...]

Published
2001

6. Anti-TNF Drugs' link to Infections Concerns FDA

Author

ZOLER, MITCHEL L.

Subjects
United States. Food and Drug Administration -- Investigations, Etanercept (Medication) -- Adverse and side effects, Enbrel (Medication) -- Adverse and side effects, Remicade (Medication) -- Adverse and side effects, Tumor necrosis factor, Infliximab -- Adverse and side effects, Tuberculosis -- Risk factors
Abstract

PHILADELPHIA -- The Food and Drug Administration has received "a substantial proportion of adverse event reports" of opportunistic infections for the two anti-tumor necrosis factor drugs on the U.S. market, [...]

Published
2001

7. Capsules; Blood Transfusions Could Save Lives of Older Heart Attack Patients

Author

Maugh, Thomas H., II

Subjects
Cardiac patients -- Care and treatment, Heart attack -- Care and treatment, Blood transfusion -- Health aspects, Aged -- Care and treatment, Oral contraceptives -- Adverse and side effects, Hypodermic syringes -- Safety and security measures, Diabetes -- Drug therapy, Hormone therapy -- Adverse and side effects, Stroke (Disease) -- Risk factors, Electrocardiogram -- Evaluation, Congestive heart failure -- Drug therapy, Medicine, Herbal -- Safety and security measures, Surgery -- Safety and security measures, General interest, News, opinion and commentary, Remicade (Medication) -- Adverse and side effects
Published
2001

8. Capsules; Appendicitis Detection Fails to Improve in Last Decade

Author

Maugh, Thomas H.

Subjects
Appendicitis -- Diagnosis, Home pregnancy tests -- Evaluation, Creutzfeldt-Jakob disease -- Drug therapy, Quinacrine -- Evaluation, Douching -- Health aspects, Vaginosis -- Risk factors, Stroke (Disease) -- Research, Tuberculosis -- Risk factors, General interest, News, opinion and commentary, Remicade (Medication) -- Adverse and side effects
Published
2001

9. Capsules; Hormone Replacement Is Effective for Older Women Too

Author

Maugh, Thomas H., II

Subjects
Aged women -- Health aspects, Hormone therapy -- Research, Bones -- Density, Hypertension -- Care and treatment, ACE inhibitors -- Adverse and side effects, Iron -- Health aspects, Cough -- Drug therapy, HIV infection, Oral sex -- Health aspects, Arthritis -- Drug therapy, General interest, News, opinion and commentary, Remicade (Medication) -- Adverse and side effects
Published
2001

10. Firm to Place Warning on Arthritis Drug

Author

Gellene, Denise

Subjects
Johnson & Johnson -- Safety and security measures, Pharmaceutical industry -- Safety and security measures, Antiarthritic agents -- Adverse and side effects, General interest, News, opinion and commentary, Remicade (Medication) -- Adverse and side effects
Published
2001

11. FDA actions

Subjects
Serono AG -- Licensing, certification and accreditation, Centocor Inc. -- Product information, Pharmaceutical industry -- Licensing, certification and accreditation, Pharmaceutical industry -- Product information, Health, Luveris (Medication) -- Licensing, certification and accreditation, Remicade (Medication) -- Adverse and side effects
Abstract

Serono has been given approval to market recombinant human luteinizing hormone (Luveris) for the treatment of infertility in women. The drug, which was granted orphan status, has been available in [...]

Published
2004

12. Remicade (Infliximab)

Subjects
Rheumatoid arthritis -- Drug therapy, Infliximab -- Adverse and side effects, Health, Remicade (Medication) -- Product information, Remicade (Medication) -- Adverse and side effects
Published
2004

13. Remicade (Infliximab)

Subjects
Infliximab -- Product information, Rheumatoid arthritis -- Drug therapy, Health, Remicade (Medication) -- Adverse and side effects, Remicade (Medication) -- Product information
Published
2004

14. New cautions for infliximab users

Author

Dunkin, Mary Anne

Subjects
Rheumatoid arthritis -- Drug therapy, Infliximab -- Adverse and side effects, Congestive heart failure -- Complications, Health, Remicade (Medication) -- Adverse and side effects
Published
2002

15. Infliximab Maker Warns Doctors of New TB Cases. (Rheumatoid Arthritis, Crohn's)

Author

Mechcatie, Elizabeth

Subjects
Remicade (Medication) -- Adverse and side effects, Infliximab -- Adverse and side effects, Pharmaceutical industry -- Safety and security measures, Tuberculosis -- Risk factors, Crohn's disease -- Risk factors
Abstract

The manufacturer of influximab, one of the two currently available tumor necrosis factor-[alpha] antagonists, has issued a "Dear Doctor" letter warning about continued case reports of tuberculosis and other opportunistic [...]

Published
2001

16. Remicade Users Run Risk Of TB, Opportunistic Infections. (Drug Update)

Subjects
Infliximab -- Adverse and side effects, Tuberculosis -- Risk factors, Opportunistic infections -- Risk factors, Health, Remicade (Medication) -- Adverse and side effects
Abstract

A new 'black box' warning has been added to product labeling for infliximab (Remicade) to alert prescribers to the risks of patients developing tuberculosis, invasive fungal infections such as histoplasmosis, [...]

Published
2001

17. Remicade warnings. (Clinical Capsules)

Subjects
Remicade (Medication) -- Adverse and side effects, Tuberculosis -- Risk factors, Histoplasmosis -- Risk factors, Listeriosis -- Risk factors, Pneumocystis carinii pneumonia -- Risk factors
Abstract

Remicade, a biologic agent for rheumatoid arthritis and Crohn's disease, has been linked to tuberculosis and other opportunistic infections, including histoplasmosis, listeriosis, and pneumocystosis, according to an Oct. 5 "Dear [...]

Published
2001

18. TB Test Required For Arthritis Patients Wishing To Take Remicade

Subjects
Centocor Inc. -- Research, Remicade (Medication) -- Adverse and side effects, Rheumatoid arthritis -- Care and treatment, Tuberculosis -- Prevention, Pharmaceutical industry -- Research
Abstract

2001 SEP 16 - (NewsRx.com & NewsRx.net) -- Rheumatoid arthritis patients must be tested for tuberculosis before they begin taking a treatment called Remicade, the drug maker and the U.S. [...]

Published
2001

19. FDA issues warnings, label changes

Subjects
Genentech Inc. -- Labeling, Aventis Pharmaceuticals Inc. -- Labeling, Centocor Inc. -- Labeling, Pharmaceutical industry -- Labeling, Infliximab -- Adverse and side effects, Infliximab -- Labeling, Chemotherapy -- Adverse and side effects, Biological products industry -- Labeling, Health care industry, Pharmaceuticals and cosmetics industries, Avastin (Medication) -- Labeling, Avastin (Medication) -- Adverse and side effects, Lovenox (Medication) -- Labeling, Remicade (Medication) -- Adverse and side effects, Remicade (Medication) -- Labeling
Abstract

The FDA and Genentech have issued a drug warning to health care providers that there is evidence of an increased risk of serious arterial thromboembolic events, including cerebrovascular accident, myocardial [...]

Published
2004

20. Centocor issues warning about Remicade. (News Briefs)

Subjects
Centocor Inc., Congestive heart failure -- Complications, Health care industry, Pharmaceuticals and cosmetics industries, Remicade (Medication) -- Adverse and side effects
Abstract

Centocor has alerted health care professionals to new safety information regarding infliximab (Remicade), its drug approved for the treatment of rheumatoid arthritis and Crohn's disease. In a suspended Phase II [...]

Published
2001

Catalog

Books, media, physical & digital resources
See catalog results